FierceBiotech 2026-02-20 Grail stock craters as key NHS-Galleri cancer blood test trial fails to hit primary endpoint
FierceBiotech 2026-02-20 Candel glows brighter with $100M RTW royalty deal to fund prostate cancer drug's launch
FierceBiotech 2026-02-19 Sanofi backs Altesa's $75M series B to bankroll antiviral's midstage rhinovirus study
FierceBiotech 2026-02-19 J&J halts enrollment in phase 2 trial of AC Immune-partnered Alzheimer's therapy
FierceBiotech 2026-02-19 GSK strikes 5-year deal with Jackson Laboratory focused on neurodegenerative disease research
FierceBiotech 2026-02-19 NIH Director Jay Bhattacharya to take over as temporary CDC chief: media reports
FierceBiotech 2026-02-18 Blood from pediatricians yields potential new medicines for respiratory viruses
FierceBiotech 2026-02-18 Novartis finds natural partner in macrocycle biotech, inking $1.7B-plus cardio deal
FierceBiotech 2026-02-18 Sensei steps back from brink by finding Faeth and its phase 2-stage cancer drug